ArticleInvestigational new drugs2026

A first-in-human phase 1a study of LP-184, a tumor-site activated novel alkylating agent, in patients with advanced solid tumors.

Daruka Mahadevan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.